Kathryn Falberg, Director at Halozyme, holds 292.61K shares in Trade Desk (Ticker: TTD), holds 149.01K shares in Arcus Biosciences (Ticker: RCUS), holds 250.00K shares in Nuvation Bio (Ticker: NUVB). Most recently, Kathryn Falberg Sold ― shares of Trade Desk on Mar 12, 2024 for an estimated value of 8.44M.
Kathryn Falberg latest transaction was an Informative Sell of $8.44M.
What was Kathryn Falberg's most profitable transaction?
Kathryn Falberg’s most profitable transaction was an Informative Buy of RCUS stock on June 11, 2019. The return on the trade was 254.00%.
What is Kathryn Falberg's role in Halozyme?
Kathryn Falberg's role in Halozyme is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.